Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (3): 675-681.doi: 10.13481/j.1671-587X.20230316
• Research in basic medicine • Previous Articles Next Articles
Desheng HUANG1,Yanan ZHAO1,Yun CHEN1,Yiyao SUN1,Weilin QIN1,Moujie LIU2,Juhua XIE1()
Received:
2022-08-01
Online:
2023-05-28
Published:
2023-06-20
Contact:
Juhua XIE
E-mail:xjh814@126.com
CLC Number:
Desheng HUANG,Yanan ZHAO,Yun CHEN,Yiyao SUN,Weilin QIN,Moujie LIU,Juhua XIE. Improvement effect of metformin on hypertrophy of H9C2 cardiomyocytes and its mechanism[J].Journal of Jilin University(Medicine Edition), 2023, 49(3): 675-681.
1 | GALDOS F X, GUO Y X, PAIGE S L, et al. Cardiac regeneration: lessons from development[J]. Circ Res, 2017, 120(6): 941-959. |
2 | PETERSON V R, NORTON G R, MADZIVA M T, et al. Metformin prevents low-dose isoproterenol-induced cardiac dilatation and systolic dysfunction in male sprague dawley rats[J]. J Cardiovasc Pharmacol, 2022, 79(3): 289-295. |
3 | HUANG K Y, QUE J Q, HU Z S, et al. Metformin suppresses inflammation and apoptosis of myocardiocytes by inhibiting autophagy in a model of ischemia-reperfusion injury[J]. Int J Biol Sci, 2020, 16(14): 2559-2579. |
4 | SMOLICH J J. Ultrastructural and functional features of the developing mammalian heart: a brief overview[J]. Reprod Fertil Dev, 1995, 7(3): 451-461. |
5 | PARK J, CHOI H, MIN J S, et al. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells[J]. J Neurochem, 2013, 127(2): 221-232. |
6 | VAN HORSSEN J, VAN SCHAIK P, WITTE M. Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders?[J]. Neurosci Lett, 2019, 710: 132931. |
7 | VEZZANI B, CARINCI M, PATERGNANI S, et al. The dichotomous role of inflammation in the CNS: a mitochondrial point of view[J]. Biomolecules, 2020, 10(10): 1437. |
8 | IKEDA Y, SHIRAKABE A, BRADY C, et al. Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system[J]. J Mol Cell Cardiol, 2015, 78: 116-122. |
9 | ROSSI A, PIZZO P, CalciumFILADI R,et al. mitochondria and cell metabolism: a functional triangle in bioenergetics[J]. Biochim Biophys Acta Mol Cell Res, 2019, 1866(7): 1068-1078. |
10 | DING M G, LIU C Y, SHI R, et al. Mitochondrial fusion promoter restores mitochondrial dynamics balance and ameliorates diabetic cardiomyopathy in an optic atrophy 1-dependent way[J].Acta Physiol (Oxf), 2020, 229(1): e13428. |
11 | DE MARAÑÓN A M, CANET F, ABAD-JIMÉNEZ Z, et al. Does metformin modulate mitochondrial dynamics and function in type 2 diabetic patients?[J]. Antioxid Redox Signal, 2021, 35(5): 377-385. |
12 | PALEE S, HIGGINS L, LEECH T, et al. Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia/reperfusion injury[J]. Biomedecine Pharmacother, 2020, 130: 110604. |
13 | TSAI C Y, KUO W W, SHIBU M A,et al. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling[J]. PLoS One, 2017, 12(9): e0184153. |
14 | OLDFIELD C J, DUHAMEL T A, DHALLA N S. Mechanisms for the transition from physiological to pathological cardiac hypertrophy[J]. Can J Physiol Pharmacol, 2020, 98(2): 74-84. |
15 | THAM Y K, BERNARDO B C, OOI J Y, et al. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets[J]. Arch Toxicol, 2015, 89(9): 1401-1438. |
16 | PEOPLES J N, SARAF A, GHAZAL N, et al. Mitochondrial dysfunction and oxidative stress in heart disease[J]. Exp Mol Med, 2019, 51(12): 1-13. |
17 | CHISTIAKOV D A, SHKURAT T P, MELNICHENKO A A, et al. The role of mitochondrial dysfunction in cardiovascular disease: a brief review[J]. Ann Med, 2018, 50(2): 121-127. |
18 | PENG W X, CAI G D, XIA Y P, et al. Mitochondrial dysfunction in atherosclerosis[J]. DNA Cell Biol, 2019, 38(7): 597-606. |
19 | CHEN Y T, CHANG Y, ZHANG N J, et al. Atorvastatin attenuates myocardial hypertrophy in spontaneously hypertensive rats via the C/EBPβ/PGC-1α/UCP3 pathway[J]. Cell Physiol Biochem, 2018, 46(3): 1009-1018. |
20 | DI NOTTIA M, VERRIGNI D, TORRACO A, et al. Mitochondrial dynamics: molecular mechanisms, related primary mitochondrial disorders and therapeutic approaches[J]. Genes (Basel), 2021, 12(2): 247. |
21 | TILOKANI L, NAGASHIMA S, PAUPE V, et al. Mitochondrial dynamics: overview of molecular mechanisms[J].Essays Biochem,2018, 62(3): 341-360. |
22 | TAN Y, XIA F F, LI L L, et al. Novel insights into the molecular features and regulatory mechanisms of mitochondrial dynamic disorder in the pathogenesis of cardiovascular disease[J]. Oxid Med Cell Longev, 2021, 2021: 6669075. |
23 | KUMAR R, BUKOWSKI M J, WIDER J M, et al. Mitochondrial dynamics following global cerebral ischemia[J]. Mol Cell Neurosci, 2016, 76: 68-75. |
24 | YAMAGUCHI R, LARTIGUE L, PERKINS G,et al. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization[J].Mol Cell,2008,31(4): 557-569. |
25 | NIIZUMA K, YOSHIOKA H, CHEN H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia[J]. Biochim Biophys Acta, 2010, 1802(1): 92-99. |
26 | CHAN D C. Mitochondrial dynamics and its involvement in disease[J]. Annu Rev Pathol, 2020, 15: 235-259. |
27 | FLANNERY P J, TRUSHINA E. Mitochondrial dynamics and transport in Alzheimer’s disease[J]. Mol Cell Neurosci, 2019, 98: 109-120. |
28 | NAN J L, ZHU W, RAHMAN M S,et al. Molecular regulation of mitochondrial dynamics in cardiac disease[J]. Biochim Biophys Acta BBA Mol Cell Res, 2017, 1864(7): 1260-1273. |
29 | DING J, ZHANG Z H, LI S, et al. Mdivi-1 alleviates cardiac fibrosis post myocardial infarction at infarcted border zone, possibly via inhibition of Drp1-Activated mitochondrial fission and oxidative stress[J]. Arch Biochem Biophys, 2022, 718: 109147. |
30 | LIU C, HAN Y, GU X,et al. Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy[J]. Redox Biol, 2021, 46: 102098. |
31 | BENES J, KOTRC M, KROUPOVA K, et al. Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)[J]. Sci Rep, 2022, 12(1): 13038. |
[1] | Chunqing MU, Lei ZHOU, Nan ZHAO, Hong WANG, Zhi LI. Effect of metformin on proliferation of lung cancer A549 cells through PI3K/AKT/GSK3β signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 637-643. |
[2] | Lei XIE, Xiaoli LIU, Jing GE, Yawei LI. Effects of baicalin combined with metformin on endocrine, inflammatory factors and insulin resistance in rats with polycystic ovary syndrome and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 623-629. |
[3] | LI Ruiyang, LIN Zhiyi, LI Jing, FEI Jing, XU Dan, GONG Ping. Changes of IGF-1 and mTOR expressions in peripheral blood of patients with non-small cell lung cancer before and after chemotherapy combined with metformin and analysis on their therapeutic effects [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 108-115. |
[4] | WANG Ruibin, ZHAO Yanjie, SONG Qingkun, SHENG Minjia. Inhibitory effect of metformin on inflammatory responseof Kupffer cells of liver in diabetic mice and its improvement on phagocytic function [J]. Journal of Jilin University(Medicine Edition), 2019, 45(01): 39-44. |
[5] | ZHAO Lijing, KANG Jing, AN Ying, XU Bo, WANG Yanchun. Eeffect of tectorigenin on myocardial fibrosis in rats and its mechanism [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 288-292. |
[6] | WANG Liyan, ZHANG Beibei, HE Dongyun, SHENG Minjia, WANG Xue. Influence of metformin and paclitaxel in proliferation and apoptosis of ovarian cancer SKOV3 cells in vitro [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 255-259. |
[7] | AN Ying, YANG Qian, HUANG Jianlu, JIANG Kai, ZENG Qingrong, SONG Wenxin, WANG Yanchun. Improvement effect of Vitacamphorae Injection on myocardial fibrosis in rats [J]. Journal of Jilin University Medicine Edition, 2015, 41(04): 737-741. |
[8] | YU Zhiyun, LI Yunqian, CHEN Yong, ZHAO Liyan, LIU Huanbing, WANG Nan, WANG Bin, CHEN Yunzhao, ZHAO Gang. Elimination of temozolomide in combination with metformin on glioma stem cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2015, 41(02): 321-326. |
[9] | LI Chang-ling,LIN Di,XING Si-ning,ZHAO Song,CHEN Hui-peng,ZHOU Fan,MA Dong-chu. Inhibitory effect of metformin on proliferation of megakaryocytic leukemia cell line Dami and its mechanism [J]. Journal of Jilin University Medicine Edition, 2014, 40(03): 534-538. |
[10] | WU Guo-dong,WANG Su-xia,JI Zhi-yong, ZHANG Shu-yan. Relationship between B-type natriuretic peptide level and liver function of rats with acute heart failure [J]. Journal of Jilin University Medicine Edition, 2013, 39(3): 517-520. |
[11] | LIU Wei,CHEN Tao,HAN Hong-bo,ZHU Kun,MA Ming-ze,WANGDan-ping,GAO Hai-cheng,JIN Ming-yu. Therapeutic effect of gink gobioba extract on diabetic cardiomyopathy induced by SZT and ISO in rats [J]. Journal of Jilin University Medicine Edition, 2013, 39(3): 503-506. |
[12] | LI Jing,CAO Hong-yan,QIN Ling. Relationships between angiotensin-converting enzyme 2 and essential hypertension and heart function [J]. J4, 2011, 37(5): 909-914. |
[13] | MIAO Chun-Sheng, GAO Hai-Cheng, LI Xiang-Jun, YIN Li, LI Yun-Qian, LI Cai. Expression of p53 in myocardium tissue of myocardial fibrosis rats induced with isoproterenol |and its significance [J]. J4, 2010, 36(6): 1064-1066. |
[14] | LIU Jin-ping,ZHAO Chun-fang,LI Ping-ya,LI Xian. Ameliorative effects of pseudoginsenoside GQ on isoproterenol-induced acute myocardial ischemia in rats [J]. J4, 2006, 32(1): 64-4. |